Cost and effectiveness thresholds of VR

February 18, 2021by SyncVR Medicalusing VR

Cost and effectiveness thresholds of VR

February 18, 2021 by SyncVR Medical

Virtual reality is emerging as a novel and cost effective non-pharmacologic therapy for pain, and there is growing interest to use VR in the acute hospital setting. Traditionally, opioid was the key for pain reliving and while it was very effective it also had many side-effects associated with it like nausea, dizziness & sedation among others. These adverse prolong the duration of patient's stay in the hospital, increased cost of healthcare and a significant decrease in patient's satisfaction.

Therefore, it has now become vital to search for non-pharmacologic treatments that contribute to the efficacy of overall pain management. This is where virtual reality comes into play, by creating a computer-generated simulation which can be explored and interacted by the users. In a recent study it was found that 65% of hospitalized patients receiving a VR experience achieved a clinically significant pain response vs. 40% of controls watching a relaxation video. VR can complement a lower dose of pain medication or will eliminate the need for medicine altogether for some patients, which will reduce the expenditure on opioids and other pain killing mechanisms.

The SyncVR-Relax & Distract explore virtual reality (VR) as a distraction intervention during treatment processes. Our systems not only cut the dependence of patients on pain reliving medications but are also affordable, lightweight, smaller and comfortable. Many use a smartphone for the display and hardware, which track the patients movements to analyze their improvement while giving the caregiver total control over what their patients see.

VR applications can teach people to manage their pain in the real world. It can train and convince a person that they have governance over their body and their experience. It demonstrates that the brain's response to injuries can be manipulated in a positive way.

en_GBEnglish (UK)